dimanche 15 novembre 2026
RechercherExplore
Source trace. Via News points to the documents behind its reporting and shows what we drew from each, so you can check any claim. How we source
Source document· March 5, 2026

WISeKey Reports FY 2025 Preliminary Financial Results

View original at globenewswire.com
WISeKey Reports FY 2025 Preliminary Financial Results WISeKey Reports FY 2025 Preliminary Financial Results Subsidiary SEALSQ Delivers 66% Year-Over-Year Revenue Growth and Advances Global Quantum-Secure Semiconductor Ecosystem Geneva, Switzerland, March 5, 2026– Ad hoc announcement pursuant to Art…
Opening lines of the source · short snapshot: read the full document at the original

Ce que nous avons tiré de cette source

The claims Via News extracted from this document. We point to the source; we don't replace it.

  • WISeKey has over 1.6 billion microchips deployed across various IoT sectors

    80% confidence
  • The 58% revenue growth for WISeKey achieved in 2025 and the strong start into 2026 clearly demonstrate the transition of our semiconductor and post-quantum strategy from investment to commercial acceleration

    80% confidence
  • WISeSat upcoming merger with a SPAC is expected to be completed in the first half of 2026

    80% confidence
  • ColibriTD and SEALSQ targeting sub-7nm wafer yield improvement from 50% to 80%

    80% confidence
  • Q1 2026 revenue is expected to exceed $4M, representing over 100% growth versus Q1 2025

    80% confidence
  • WISeKey expects FY 2026 revenue growth of +50% to +100% year-over-year

    80% confidence
  • Initial revenues from QS7001 and QVault TPM expected in late 2026

    80% confidence
  • WISeKey expects to publish its audited full-year financial statements on or before April 30, 2026

    80% confidence
  • Under the NSA's CNSA 2.0 policy, all new National Security Systems must be quantum-resistant by Jan. 1, 2027

    80% confidence

Cité dans ces articles de Via News

Ce que nous savons · l'intelligence derrière cette page
En direct du substrat
Ce que nous observons
Q4 2026 Biotech Catalyst Cluster: Late-Stage Data and PDUFA Dates Converge
Early-to-mid November 2026 is a dense run of clinical readouts and Q3 earnings at AHA, AASLD, ACR and ASH. Mid-cap biotechs (Vir, Mineralys, Arrowhead, Oryzon, Novartis, J&J) are reporting data that feeds into regulatory decisions. The next ones are the ivonescimab BLA (Nov 14) and the lorundrostat PDUFA (Dec 22), followed by ECLIPSE 2/3 and Maritime-1 readouts in Q1 2027. The list also includes an unrelated delisting track (EGM Nov 19, application Jan 25, 2027), and the facts have no AI or fintech content.
Notre lecture des données ›
Signaux que nous suivons
Satellite-Terrestrial Network Integration Acceleration
Increased investment and launches in hybrid satellite-cellular networks across telecom industry; competitive responses from other carriers; regulatory activity around satellite spectrum; expansion of emergency/rural connectivity use cases
Tendances que nous surveillons ›
Là où les sources divergent
Ford Motor Company
Both facts give cash for Ford Motor Company at the same point in time (2025-12-31; FY 2025 year-end and Q4 2025 year-end are the same date). Both are labelled USD, but the values are 23,356,000,000 and 23.356, which cannot both be true in USD. The two numbers agree once the second is read as billions (23.356 bn = 23,356,000,000), so the economic content is consistent and the conflict is a unit/scale error in the Q4 2025 record. The period is not the reason for the conflict: a Q4 and an FY figure at the same year-end date should match.
Nous signalons les conflits ouvertement ›
Vérifié récemment
✓ Vérifié avec la source d'origine
4,997
faits reliés à leur source, et nous signalons ceux qui ne tiennent pas.
101 entités suivies4,997 faits vérifiés avec la source5,585 documents sources archivés
Interrogez ces données → isubstrate.com
WISeKey Reports FY 2025 Preliminary Financial Results: Source | Via News | fr.via.news